Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Archives of Gynecology and Obstetrics
Published in: Archives of Gynecology and Obstetrics 5/2011

01-05-2011 | Materno-fetal Medicine

Rectal versus oral misoprostol for active management of third stage of labor: a randomized controlled trial

Authors: H. A. Mansouri, N. Alsahly

Published in: Archives of Gynecology and Obstetrics | Issue 5/2011

Login to get access

Abstract

Aim of the study

To test that rectal misoprostol is effective for active management of third stage of labor, and probably with less side effects than oral misoprostol.

Materials and methods

As much as 658 patients were randomly allocated to receive either 600 μg misoprostol orally or rectally 5 min after cord clamping and cutting. The primary outcome was incidence of postpartum hemorrhage. Secondary outcomes included amount of blood loss, duration of third stage of labor, incidence of side effects, pre- and post-delivery hemoglobin, and the use of additional uterotonics.

Results

A total of 331 patients received 600 μg of misoprostol orally, while 327 rectally. Both groups were comparable in demographic data and neonatal outcome. Oral misoprostol was associated with significantly more blood loss than rectal (P = 0.016). Shivering and pyrexia occurred in 161 (52.1%) and 86 (27.8%) women receiving oral misoprostol, and in 81 (26.2%) and 47 (15.2%) of those who received rectal misoprostol, respectively (P = 0.000 and 0.001).

Conclusion

Rectal misoprostol is effective in the management of third stage of labor, and with a significant decrease in side effects. Lesser dose and other routes could be explored in the future.
Literature
1.
Villar J, Gulmezoglu AM, Hofmeyr GJ, Forna F (2002) Systematic review of randomized controlled trials of misoprostol to prevent postpartum hemorrhage. Obstet Gynecol 100:1301–1312PubMedCrossRef
2.
ACOG Practice Bulletin. Postpartum hemorrhage. ACOG number 76, October 2006
3.
Derman RJ, Kodkany BS, Goudar SS et al (2006) Oral misoprostol in preventing postpartum hemorrhage in a resource poor communities: a randomized controlled trial. Lancet 368(9543):1248–1253PubMedCrossRef
4.
El-Refaey H, O Brien P, Morafa W, Walder J, Rodeck C (1996) Misoprostol for third stage of labor. Lancet 347:1257PubMedCrossRef
5.
Diab KM, Rami AR, Yehia MA (1999) Use of rectal misoprostol as active pharmacological management of the third stage of labor. J Obstet Gynecol Res 25(5):327–332CrossRef
6.
Hofmeyr GJ, Nikdem VC, de Jager M, Gelbart BR (1998) A randomized placebo controlled trial of oral misoprostol in the third stage of labour. Br J Obstet Gynaecol 105(9):971–975PubMedCrossRef
7.
Bamigboye AA, Merrel DA, Hofmeyr GJ, Mitchell R (1998) Randomized comparison of rectal misoprostol with syntometrine for management of third stage of labor. Acta Obstet Gynecol Scand 77(2):178–181PubMedCrossRef
8.
Gerstenfeld TS, Wing DA (2001) Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery. Am J Obstet Gynecol 185(4):878–882PubMedCrossRef
9.
Karkanis SG, Caloia D, Salenieks ME, Kingdom J, Walker M, Meffe F, Windrim R (2002) Randomized controlled trial of rectal misoprostol versus oxytocin in third stage management. J Obstet Gynaecol Can 24(2):149–154PubMed
10.
Caliskan E, Meydanli MM, Dilbaz B, Aykan B, Sonmezer M, Haberal A (2002) Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial. Am J Obstet Gynecol 187(4):1038–1045PubMedCrossRef
11.
Vimala N, Mittal S, Kumar S, Dadhwal V, Mehta S (2004) Sublingual misoprostol versus methylergometrin for active management of third stage of labor. Int J Gynaecol Obstet 87(1):1–5PubMedCrossRef
12.
Chandhiok N, Dhillon BS, Datey S, Mather A, Saxena NC (2006) Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India. Int J Gynecol Obstet 92(2):170–175CrossRef
13.
Vimala N, Mittal S, Kumar S (2006) Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section. Int J Gynaecol Obstet 92(2):106–110PubMedCrossRef
14.
Walraven G, Blum J, Dampha Y, Sowe M, Morison L, Winikoff B, Sloan N (2005) Misoprostol in the management of the third stage of labor in the home delivery setting of Gambia: a randomized controlled trial. BJOG 112(9):1277–1283PubMedCrossRef
15.
Parson SM, Walley RL, Crane JM, Matthews K, Hutchens D (2006) Oral misoprostol versus oxytocin in the management of the third stage of labour. J Obstet Gynaecol Can 28(1):20–26
16.
Kushagi P, Verghese LM (2006) Evaluation of two uterotonic medications for the management of third stage of labor. Int J Gynaecol Obstet 94(1):47–48CrossRef
17.
Prata N, Hamza S, Gypson R, Nada K, Vahidnia F, Potts M (2006) Misoprostol and active management of the third stage of labor. Int J Gynaecol Obstet 94(2):149–155PubMedCrossRef
18.
Ng PS, Lai CY, Sahota DS, Yuen PM (2007) A double–blind randomized controlled trial of oral misoprostol and intramuscular syntometrin in the management of the third stage of labor. Gynecol Obstet Invest 63(1):55–60PubMedCrossRef
19.
Parsons SM, Walley RL, Crane JM, Matthews K, Hutchens D (2007) Rectal misoprostol versus oxytocin in the management of the third stage of labour. J Obstet Gynaecol Can 29(9):711–718PubMed
20.
Enakpene CA, Morhason-Bello IO, Enakpene EO, Arowojolu AO, Omigbodun AO (2007) Oral misoprostol for the prevention of primary postpartum hemorrhage during third stage of labor. J Obstet Gynaecol Res 33(6):810–817PubMedCrossRef
21.
Chhbra S, Tickoo C (2008) Low-dose sublingual misoprostol versus methylergometrine for active management of the third stage of labor. J Obstet Gynaecol Res 34(5):820–823CrossRef
22.
Gulmezoglu AM, Forna F, Villar J, Hofmeyr GJ (2008) Prostaglandins for preventing postpartum hemorrhage. Cochrane Database of Systematic Reviews. 2
23.
Hofmeyr GJ, Gülmezoglu AM, Novikova N, Linder V, Ferreira S, Piaggio G (2009) Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects. Bull World Health Organ 87(9):666–677PubMedCrossRef
24.
Prata N, Sreevisa A, Greig F, Walsh J, Potts M (2010) Setting priorities for safe motherhood interventions in a resource-scarce settings. Health Policy 94(1):1–13PubMedCrossRef
25.
Khan RU, El-Refaey H (2003) Pharmacokinetics and adverse-effect profile of rectally administered misoprostol in the third stage of labor. Obstet Gynecol 101(5 Pt 1):968–974PubMedCrossRef
26.
Khan RU, El-Refaey H, Sharma S, Sooranna D, Stafford M (2004) Oral, rectal, and vaginal pharmacokinetics of misoprostol. Obstet Gynecol 103(5 Pt 1):866–870PubMedCrossRef
27.
Surbek DV, Fehr PM, Hosli I, Holzgreve W (1999) Oral misoprostol for third stage of labor: a randomized placebo-controlled trial. Obstet Gynecol 94(2):255–258PubMedCrossRef
28.
Singh G, Radhakrishnan G, Guleria K (2009) Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor. Int J Gynaecol Obstet 107(2):130–134 (Epub 2009 Jul 22)
Metadata
Title
Rectal versus oral misoprostol for active management of third stage of labor: a randomized controlled trial
Authors
H. A. Mansouri
N. Alsahly
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Archives of Gynecology and Obstetrics / Issue 5/2011
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-010-1466-5

Other articles of this Issue 5/2011

Archives of Gynecology and Obstetrics 5/2011 Go to the issue

Materno-Fetal Medicine

Transient tachypnea of the newborn: effects of labor and delivery type in term and preterm pregnancies

Gynecologic Oncology

The use of MRI for selecting patients with endometrial cancer and significant co-morbidities for vaginal hysterectomy

Materno-fetal Medicine

An analysis of HELLP syndrome cases: does platelet count predict adverse maternal and fetal outcomes in women with HELLP syndrome?

Materno-fetal Medicine

Ruptured uterus: the unabating obstetric catastrophe in South eastern Nigeria

General Gynecology

94 months follow-up after laparoscopic assisted vaginal resection of septum rectovaginale and rectosigmoid in women with deep infiltrating endometriosis

General Gynecology

Intercellular adhesion molecule-1 (ICAM-1) gene polymorphism and endometriosis in northern Iran